CAS: 1432908-05-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | FRAX1036 REF: AN-AG009CMJCAS: 1432908-05-8 | 98+% | 59.00 €~492.00 € | Wed 24 Jul 24 |
 | FRAX1036 REF: TM-T6839CAS: 1432908-05-8 | 99.95% | 51.00 €~500.00 € | Wed 31 Jul 24 |
 | FRAX1036 REF: 3D-HHC90805CAS: 1432908-05-8 | Min. 95% | To inquire | Wed 04 Sep 24 |
FRAX1036
CAS:1432908-05-8
Formula:
C28H32ClN7O
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
518.0530
Ref: AN-AG009CMJ
| 1mg | 59.00 € | ||
| 5mg | 75.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 148.00 € | ||
| 50mg | 162.00 € |
Estimated delivery in United States, on Wednesday 24 Jul 2024
FRAX1036
CAS:1432908-05-8
FRAX-1036 is a effective and selective PAK1 inhibitor.
Formula:
C28H32ClN7O
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
518.05
Ref: TM-T6839
| 1mg | 51.00 € | ||
| 1ml | 96.00 € | ||
| 2mg | 68.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 207.00 € | ||
| 50mg | 346.00 € | ||
| 100mg | 500.00 € |
Estimated delivery in United States, on Wednesday 31 Jul 2024
FRAX1036
CAS:1432908-05-8
FRAX1036 is a new molecule which inhibits the cancer-promoting activity of epidermal growth factor (EGF). …
Formula:
C28H32ClN7O
Purity:
Min. 95%
Molecular weight:
518.05 g/mol
Ref: 3D-HHC90805
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Sep 2024
